Trial intelligence / Profile preview

Melatonin and Nighttime Blood Pressure in African Americans

NCT01114360Phase 2Completed

Sponsor
Emory University
Start
Mar 2010
Primary completion
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in hypertension (HTN) comparing Melatonin with Placebo (2 arms). Primary endpoints: Mean Nighttime Systolic Blood Pressure at 4 weeks and Mean Nighttime Diastolic Blood Pressure at 4 weeks. Started Mar 2010; status: completed.

02

Drugs

melatonin
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01114360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01114360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call